CDKN2A and adenocarcinoma: For example, negativity for estrogen receptor (ER), progesterone receptor (PR), P16, and CD10, as well as positivity for carcinoembryonic antigen (CEA), diffuse p16, CD34, and HPV, suggests adenocarcinoma.